| dc.contributor.author | Bousquet, J. and Pham-Thi, N. and Bedbrook, A. and Agache, I. and Annesi-Maesano, I. and Ansotegui, I. and Anto, J.M. and Bachert, C. and Benveniste, S. and Bewick, M. and Billo, N. and Bosnic-Anticevich, S. and Bosse, I. and Brusselle, G. and Calderon, M.A. and Canonica, G.W. and Caraballo, L. and Cardona, V. and Carriazo, A.M. and Cash, E. and Cecchi, L. and Chu, D.K. and Colgan, E. and Costa, E. and Cruz, A.A. and Czarlewski, W. and Durham, S. and Ebisawa, M. and Erhola, M. and Fauquert, J.-L. and Fokkens, W.J. and Fonseca, J.A. and Guldemond, N. and Iinuma, T. and Illario, M. and Klimek, L. and Kuna, P. and Kvedariene, V. and Larenas-Linneman, D. and Laune, D. and Le, L.T.T. and Lourenço, O. and Malva, J.O. and Marien, G. and Menditto, E. and Mullol, J. and Münter, L. and Okamoto, Y. and Onorato, G.L. and Papadopoulos, N.G. and Perala, M. and Pfaar, O. and Phillips, A. and Phillips, J. and Pinnock, H. and Portejoie, F. and Quinones-Delgado, P. and Rolland, C. and Rodts, U. and Samolinski, B. and Sanchez-Borges, M. and Schünemann, H.J. and Shamji, M. and Somekh, D. and Togias, A. and Toppila-Salmi, S. and Tsiligianni, I. and Usmani, O. and Walker, S. and Wallace, D. and Valiulis, A. and Van der Kleij, R. and Ventura, M.T. and Williams, S. and Yorgancioglu, A. and Zuberbier, T. | |
| dc.contributor.department | University Hospital Montpellier, Montpellier, France; MACVIA-France, Fondation partenariale FMC VIA-LR, Montpellier, France; INSERM U1168, VIMA, Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France; Université Versailles St-Quentin-en Yvelines, UMR-S 1168, Montigny le Bretonneux, France; Euforea, Brussels, Belgium; Charité, Universitätsmedizin Berlin, Humboldt-Universitätzu Berlin, Berlin, Germany; Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin, Germany; EUFOREA, Brussels, Belgium; Allergy Department, Pasteur Institute, Paris, France; Faculty of Medicine, Transylvania University, Brasov, Romania; Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM and Sorbonne Universités, Medical School Saint Antoine, Paris, France; Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain; ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium; National Center of Expertise in Cognitive Stimulation (CEN STIMCO), Broca Hospital, Paris, France; Mines ParisTech CRI - PSL Research University, Fontainebleau, France; iQ4U Consultants Ltd, London, United Kingdom; Independent Consultant, Joensuu, Finland; Woolcock Institute of Medical Research, University of Sydney, Woolcock Emphysema Centre, Sydney Local Health District, Glebe, NSW, Australia; Allergist, La Rochelle, France; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Imperial College London-National Heart and Lung Institute, London, United Kingdom; Personalized Medicine Clinic Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano (MI), Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy; Institute for Immunological Research, University of Cartagena, Campus de Zaragocilla, Edificio Biblioteca Primer piso, Cartagena, Colombia; Foundation for the Development of Medical and Biological Sciences, Cartagena, Colombia; Allergy Section, Department of Internal Medicine, Hospital Vall d’Hebron and ARADyAL research network, Barcelona, Spain; Regional Ministry of Health of Andalusia, Seville, Spain; College of Psychology, Nova Southeastern University, School-related Psychological Assessments and Clinical Interventions Clinic, Ft Lauderdale, FL, United States; SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy; Department of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Health, Social Services and Public Safety, Northern Ireland, Belfast, United Kingdom; UCIBIO, REQUIMTE, Faculty of Pharmacy, and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), University of Porto, Porto, Portugal; ProAR-Nucleo de Excelencia em Asma, Federal University of Bahia, Brasil and WHO GARD Executive Committee, Bahia, Brazil; Medical Consulting Czarlewski, Levallois, France; Allergy and Clinical Immunology Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan; National Institute for Health and Welfare, Helsinki, Finland; CHU Clermont-Ferrand, Unité d’Allergologie de l’Enfant, Pôle Pédiatrique, Hôpital Estaing, Clermont-Ferrand, France; Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, Netherlands; CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto, Medida, Lda Porto, Portugal; Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, Netherlands; Department of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan; Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R and D and DISMET), Naples, Italy; Center for Rhinology and Allergology, Wiesbaden, Germany; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland; Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, Institute of Clinical Medicine, Clinic of Chest diseases and Allergology, Faculty of Medicine, Vilnius, Lithuania; Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico; KYomed INNOV, Montpellier, France; University of Medicine and Pharmacy, Hochiminh City, Viet Nam; Faculty of Health Sciences and CICS-UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal; CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, Naples, Italy; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain; Danish Committee for Health Education, Copenhagen East, Denmark; Division of Infection, Immunity and Respiratory Medicine, Royal Manchester Children’s Hospital, University of Manchester, Manchester, United Kingdom; Allergy Department, 2nd Pediatric Clinic, Athens General Children’s Hospital “P and A Kyriakou”, University of Athens, Athens, Greece; University of Oulu, Faculty of Medicine, Oulun Yliopisto, Finland; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Phillipps-Universität Marburg, Germany; Department of Health and Social Services, Welsh Government, Cardiff, United Kingdom; Centre For Empowering Patients and Communities, Dublin, Ireland; Asthma UK Centre for Applied Research, Usher Institute of Population Health Sciences and Informatics, The, University of Edinburgh, Edinburgh, United Kingdom; Agency for Social Services and Dependency, Regional Government for Equality, Social Policies and Conciliation of Andalucia, Seville, Spain; Association Asthme et Allergie, Paris, France; KanopyMed, Paris, France; Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland; Allergy and Clinical Immunology Department, Centro Medico-Docente La Trinidad, Caracas, Venezuela; Immunomodulation and Tolerance Group, Imperial College London, and, Allergy and Clinical Immunology, Imperial College London, London, United Kingdom; European Health Futures Forum (EHFF), Dromahair, Ireland; Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, United States; Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland; Health Planning Unit, Department of Social Medicine, Faculty of Medicine, University of Crete, Crete, Greece; International Primary Care Respiratory Group IPCRG, Aberdeen, United Kingdom; National Heart and Lung Institute (NHLI), Imperial College London, Royal Brompton Hospital, Airways Disease Section, London, United Kingdom; Asthma UK, London, United Kingdom; Nova Southeastern University, Fort Lauderdale, FL, United States; Vilnius University Faculty of Medicine, Institute of Clinical Medicine, Institute of Health Sciences, Vilnius, Lithuania; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands; University of Bari Medical School, Unit of Geriatric Immunoallergology, Bari, Italy; International Primary Care Respiratory Group IPCRG, Aberdeen, United Kingdom; Department of Pulmonary Diseases, Celal Bayar University, Faculty of Medicine, Manisa, Turkey; Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Uniersität zu Berlin, Berlin Institute of Health, Comprehensive Allergy-Centre, Department of Dermatology and Allergy, Berlin, Germany; CHU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, Montpellier Cedex 5, 34295, France | |
